Zoetis (ZTS) Reports Q3 Earnings: What Key Metrics Have to Say

For the quarter ended September 2026, Zoetis (ZTS) reported revenue of $2.39 billion, down 0.4% over the same period last year. EPS came in at $1.75, compared to $1.70 in the year-ago quarter.

The reported revenue represents a surprise of +3.89% over the Zacks Consensus Estimate of $2.3 billion. With the consensus EPS estimate being $1.51, the EPS surprise was +15.89%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Zoetis performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Geographic Revenues- U.S.- Companion Animal: $980 million versus the three-analyst average estimate of $915.2 million. The reported number represents a year-over-year change of -8.3%.

• Geographic Revenues- International- Companion Animal: $585 million versus the three-analyst average estimate of $583.85 million. The reported number represents a year-over-year change of +0.3%.

• Geographic Revenues- International- Livestock: $531 million versus the three-analyst average estimate of $492.19 million. The reported number represents a year-over-year change of +12.5%.

• Geographic Revenues- U.S.- Livestock: $266 million versus $264.8 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +5.1% change.

• Geographic Revenues- International Revenue: $1.12 billion compared to the $1.11 billion average estimate based on two analysts. The reported number represents a change of +5.8% year over year.

• Geographic Revenues- U.S.: $1.25 billion compared to the $1.17 billion average estimate based on two analysts. The reported number represents a change of -5.8% year over year.

• Revenues- Companion Animal: $1.57 billion versus $1.51 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a -5.3% change.

• Revenues- Contract Manufacturing & Human Health: $29 million compared to the $23.61 million average estimate based on three analysts. The reported number represents a change of +26.1% year over year.

• Revenues- Livestock: $797 million versus the three-analyst average estimate of $752.76 million. The reported number represents a year-over-year change of +9.9%.